Volume 48, Issue 4 pp. 1156-1157
Research Article

Erysipelothrix rhusiopathiae septic arthritis

Maria E. Ruiz

Corresponding Author

Maria E. Ruiz

FDA, Rockville, Maryland

Food and Drug Administration, HFD-590, 5600 Fishers Lane, Rockville, MD 20857Search for more papers by this author
J. Steuart Richards

J. Steuart Richards

Veterans Affairs Medical Center, Washington, DC

Search for more papers by this author
Gail S. Kerr

Gail S. Kerr

Veterans Affairs Medical Center, Washington, DC

Search for more papers by this author
Virginia L. Kan

Virginia L. Kan

Veterans Affairs Medical Center, Washington, DC

Search for more papers by this author
First published: 03 April 2003
Citations: 26

The views expressed in this article are those of the authors and do not necessarily reflect the policies of the US Food and Drug Administration.

Abstract

We describe herein the case of a man with Erysipelothrix rhusiopathiae septic arthritis and possible infective endocarditis. This is the first report in the English-language medical literature of septic arthritis caused by this organism.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me